The misbalance between pro-inflammatory IL-1𝛽 and anti-inflammatory IL-4 in patients with chronic generalized periodontitis

dc.contributor.authorKhudiakova, Maryna
dc.contributor.authorRyabokon, Y.
dc.date.accessioned2019-12-01T16:31:58Z
dc.date.available2019-12-01T16:31:58Z
dc.date.issued2019
dc.description.abstractThe research in question demonstrates lipoflavon capability to normalize homeostasis of the oral cavity, normalize misbalance of cytokines in periodontal tissues, thus retarding process of inflammation and destruction of tissues and improving reparation of periodontal structures. High therapeutic efficiency of the liposomal quercetin-lecithin complex for patients with chronic generalized periodontitis, especially that of initial-I degrees of severity was shown to be determined by anti-inflammatory, immunomodulating and periodontoprotecting effects. This allows to recommend lipoflavon for local application as pathogenetically substantiated drug in treatment of generalized periodontitis.ru_RU
dc.identifier.citationKhudiakova M. The misbalance between pro-inflammatory IL-1𝛽 and anti-inflammatory IL-4 in patients with chronic generalized periodontitis / M. Khudiakova, Y. Ryabokon // Механізми розвитку патологічних процесів і хвороб та їхня фармакологічна корекція : ІІ науково-практична internet-конференція з міжнародною участю, 21 листопада 2019 року, м. Харків. ‒ Харків, 2019. – С. 27‒29.ru_RU
dc.identifier.urihttps://repo.knmu.edu.ua/handle/123456789/25137
dc.language.isoenru_RU
dc.subjectpro-inflammatory IL-1𝛽ru_RU
dc.subjectanti-inflammatory IL-4ru_RU
dc.subjectchronic generalized periodontitisru_RU
dc.titleThe misbalance between pro-inflammatory IL-1𝛽 and anti-inflammatory IL-4 in patients with chronic generalized periodontitisru_RU
dc.typeArticleru_RU

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Khudiakova 2.pdf
Size:
995.72 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
11.51 KB
Format:
Item-specific license agreed upon to submission
Description: